Phase I Clinical Study of AV-1959R: Abeta-targeting Anti-Alzheimer's Vaccine

NCT06831812 · clinicaltrials.gov ↗

PHASE1

Phase

COMPLETED

Status

16

Enrollment

INDUSTRY

Sponsor class

Conditions

Alzheimer Disease
Alzheimer Disease (AD)
Alzheimers Disease Prevention

Interventions

BIOLOGICAL: AV-1959R (Abeta vaccine)

Sponsor

Nuravax, Inc.

Collaborators

[object Object]